Products

Genix.ai
Genix.ai
Clinical Decision Support & Reference
Genix.ai delivers AI-assisted SaaS healthcare software for hospitals, laboratories, and regulated healthcare teams that need faster, more explainable clinical annotation without compromising expert oversight. The company brings advanced genetic testing and DNA sequencing into a refined at-home experience, helping individuals and families move beyond a routine health check-up and towards earlier, more informed health decisions.

See all 1 product →

About Genix.ai

Genix.ai is a healthcare technology company focused on advancing precision medicine through the integration of artificial intelligence and genomic science. The company develops AI-native platforms for clinical genomics, aiming to provide advanced clinical analysis by interpreting genetic data and medical imaging using machine learning-powered pipelines. This enables healthcare providers to gain deeper insights into diseases and identify effective, personalized treatment options. [1, 2, 3, 6]

For physicians, Genix.ai offers solutions designed to strengthen clinical decision-making, accelerate biomedical research, and support public health outcomes. [3] Their platforms are built with explainability, security, scalability, and human oversight in mind, ensuring trusted AI integration in regulated clinical environments. [3] This includes support for various stages of the genomic value chain, such as variant interpretation, diagnostic and laboratory intelligence, secure deployment of AI models, and workflow enhancement through enterprise healthcare software. [3] The company emphasizes a research-driven platform development, close collaboration with clinicians and health systems, and real-world pilot programs for AI integration. [3]

Genix.ai’s offerings extend to supporting population genomics studies, genomic epidemiology and surveillance, and translational research for public health programs. [11] They also provide a genomics-led platform for the pharmaceutical and biotech industries, assisting research teams in biomarker discovery, translational science, and clinical development with AI-assisted workflows and smarter cohort selection for clinical trials. [12]

Focus Areas

AI-driven genomics precision medicine clinical genomics genomic intelligence DNA testing clinical annotation population health biomarker discovery drug development

Business Intelligence

Key InvestorsSASTRA ABLEST, JAIN Launchpad
PartnershipsHospitals & Health Systems, Diagnostic Laboratories, Pharma & Biotech, Research Institutions & Public Sector, Channel & B2C Distribution Partners
Acquisitionsunknown
TechnologyAI-native platforms, cloud-native architecture, AI-bioinformatics stack, SaaS deployment models, ambient voice recognition, automated medical documentation, multilingual support, predictive analytics, secure data encryption, EHR integration
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

AI-Driven Genomics & Precision Medicine
Genix.ai leverages AI and Next-Generation Sequencing (NGS) to detect biomarkers early, enabling personalized treatments for rare pediatric conditions, cancer care, and infectious diseases. They offer comprehensive genetic reports covering general well-being, athletic performance, nutrition, skin health, allergy predispositions, genetic risk for common cancers, and hereditary disorders.
Clinical Genomics & Genomic Intelligence
The company provides a clinically grounded genomics intelligence platform that integrates into hospital workflows, supporting DNA-led care delivery. Their platform offers AI-powered clinical annotation and genomic intelligence for diagnostic laboratories, bioinformaticians, pharma & biotech, and public health.
Population Health & Biomarker Discovery
Genix.ai offers a population-scale genomics intelligence platform for longitudinal, multi-cohort, and multi-institutional research. This includes analyzing genomic data across diverse populations, integrating clinical, environmental, and demographic context, and enabling real-time insights for public health. They also strengthen biomarker discovery and validation with AI-assisted workflows.
Drug Development
Genix.ai supports AI in drug development by providing a genomics-led platform for pharmaceutical and biotech teams. It helps convert genomic evidence into structured, explainable outputs for biomarker discovery, translational science, and clinical development, accelerating AI in clinical trials with smarter cohort selection.
Key Differentiators
Genix.ai emphasizes 'Science Before Hype,' grounding solutions in evidence and clinical relevance. They position AI as assistance, not authority, strengthening human expertise. Their 'Population Awareness Matters' principle ensures broader representation and inclusive insight generation, incorporating high-resolution South Asian and Indian benchmarks to reduce misinterpretation in diverse ethnic groups. 'Governance as a Core Feature' ensures auditability, transparency, and institutional control with 'Privacy by Design' principles.
Technology Stack
Their AI-bioinformatics stack is organized into five layers: Data Ingestion & Validation, Bioinformatics Processing Pipelines, Feature Engineering & Representation, AI/ML Intelligence Models, and Interpretation, Explainability & Governance. They utilize next-generation sequencing (NGS) and AI-powered genomic interpretation pipelines validated against international benchmarks, delivering insights with over 99.9% accuracy.
Physician Tip

For physicians, Genix.ai acts as a clinical decision support platform, providing AI-assisted interpretation of genomic findings while ensuring final sign-off remains with qualified clinicians. The platform offers explainable analytical outputs, structured summaries, and visualization layers to make complex genomic findings interpretable. It supports interpreting genomic data with clinical context, scaling from individual cases to population programs, and accelerating diagnoses with faster turnaround insights. Their focus on population-specific genomic data helps reduce the risk of clinical misinterpretation in diverse ethnic groups.

Genix.ai offers standardized APIs and supports global data standards like GA4GH, enabling integration with national health registries, cancer registries, and electronic health records for a unified view of population health. They also offer flexible deployment models, including SaaS, Private VPC, and On-Premise, to align with hospital IT policies and data sovereignty requirements. While the provided information mentions integrations with various systems for a different 'Genix AI' (telehealth platform), for Genix.ai (genomics), the focus is on robust data standards and deployment flexibility for healthcare systems.

Products by Genix.ai

1 product in the directory

Genix.ai
Genix.ai
Clinical Decision Support & Reference
Genix.ai delivers AI-assisted SaaS healthcare software for hospitals, laboratories, and regulated healthcare teams that need faster, more explainable clinical annotation without compromising expert oversight. The company brings advanced genetic testing and DNA sequencing into a refined at-home experience, helping individuals and families move beyond a routine health check-up and towards earlier, more informed health decisions.

Reviews & Opinions

No web reviews on file yet for Genix.ai. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Genix.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Genix.ai →

View all on YouTube

Press & Coverage

Genix AI
Genix AI is an AI-powered telehealth platform that offers tools such as real-time transcription, multilingual support, and predictive analytics to streamline healthcare delivery.
Genix AI offers an AI-powered telehealth platform with real-time transcription, multilingual support, and predictive analytics to enhance healthcare delivery and integrate with systems like the NHS.
2025-08
PitchBook
Genix.AI 2026 Company Profile: Valuation, Funding & Investors | PitchBook
Genix.AI, founded in 2021 and headquartered in Bangalore, India, is a private company in the healthcare technology industry that has received investment from SASTRA ABLEST and JAIN Launchpad.
2026-07
Vestbee
Polish biotech startup Ingenix.ai secures u20ac9M for simulating clinical trials with AI | Vestbee
Warsaw-based biotech startup Ingenix.ai secured u20ac9 million in funding from Inovo, OTB Ventures, and IFC to simulate clinical trials using AI and digital twins.
2025-04
Generix
Generix Announces New AI-Powered Resource Management System (RMS) to Intelligently Optimize All Warehouse Resources
Generix launched its new AI-powered Resource Management System (RMS) on April 28, 2025, designed to optimize all warehouse resources through intelligent forecasting, planning, and analytics.
2025-04
Hygenix, Inc.
FDA's AI Push | Hygenix, Inc.
The FDA announced on May 12, 2025, that it will expand its use of generative AI in regulatory review processes for drugs, medical devices, and food safety, building on a successful pilot program.
2025-05
JMIR Medical Informatics
Preliminary Evidence of the Use of Generative AI in Health Care Clinical Services: Systematic Narrative Review - JMIR Medical Informatics
A systematic review of articles published between January 2020 and May 2023 found that generative AI (GenAI) is increasingly used in healthcare to assist, guide, and automate clinical services, primarily for knowledge access, disease detection, diagnosis, and screening.
2024-03
ABB
Helping industries do better with generative AI: ABB launches Genix Copilot with Microsoft
ABB launched ABB Abilityu2122 Genix Copilot in collaboration with Microsoft on December 11, 2024, a generative AI solution designed to enhance efficiency, productivity, and sustainability in industrial operations by contextualizing vast amounts of data.
2024-12
openPR.com
AI in Genomics Market to Reach USD 6.5 Billion by 2035 | Precision - openPR.com
According to Market Genics, the AI in Genomics Market is projected to reach USD 6.5 billion by 2035, growing at a CAGR of 27.8% from an estimated USD 0.6 billion in 2025, driven by AI's role in genomic research and precision medicine.
2026-07

Frequently Asked Questions

Genix.ai provides AI-powered platforms designed to analyze complex genomic data, offering insights for personalized treatment plans and precision medicine. Our solutions assist in identifying relevant genetic variations, predicting drug responses, and stratifying patient populations for targeted therapies.
Genix.ai leverages advanced machine learning algorithms and a continuously updated knowledge base to ensure high accuracy in genomic intelligence and clinical annotation. Our processes involve rigorous validation against established clinical guidelines and expert-curated databases to provide clinically actionable insights.
Genix.ai prioritizes data security and patient privacy through robust encryption, access controls, and de-identification protocols. We are committed to full compliance with global healthcare regulations, including HIPAA and GDPR, ensuring all genomic data is handled with the highest standards of confidentiality and integrity.
Yes, Genix.ai's platform is designed for seamless integration with various EHR systems. We offer flexible APIs and customizable integration solutions to ensure that genomic insights are readily accessible within existing clinical workflows, minimizing disruption and enhancing decision-making.
Genix.ai supports population health by enabling the analysis of large-scale genomic datasets to identify disease trends and risk factors within specific populations. For drug development, our platform facilitates biomarker discovery by pinpointing genetic markers associated with disease susceptibility, progression, and drug response, accelerating the development of novel therapeutics.
Genix.ai offers flexible pricing models tailored to the specific needs and scale of our clients, including subscription-based and usage-based options. We provide comprehensive technical support, including dedicated account managers, 24/7 online resources, and customized training programs to ensure optimal utilization of our platforms.
Genix.ai is committed to long-term innovation in AI-driven genomics, continuously expanding our research and development efforts. We have established strategic partnerships with leading academic institutions, pharmaceutical companies, and healthcare providers to advance precision medicine and integrate genomic intelligence into mainstream healthcare.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.